Navigation Links
NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
Date:4/8/2013

thin five years, and to eventually expand into other solid tumors that over-express EGFR and tend to metastasize to the brain."

Mr. Pedersen noted that NT-113 and additional analogs are currently in preclinical development, and that NewGen expects to file an Investigational New Drug (IND) application to begin clinical trials with NT-113 in 2014.

About NewGen
NewGen Therapeutics is a privately held pharmaceutical company developing patient-targeted cancer drugs that are designed to overcome limitations of currently available therapies. The company's pipeline includes multiple programs with novel small molecule drug leads against clinically important targets, each addressed to significant medical needs. NT-113, a potent irreversible pan-ErbB inhibitor, is the company's most advanced program and has demonstrated anti-cancer activity in several cancer xenograft studies, including GBM, gastric cancer and NSCLC.  NT-113 will enter Phase 1 clinical trials in 2014.  In addition, NewGen's pipeline includes NT-004, a reversible pan-ErbB inhibitor and NT-125, a PARP inhibitor, both in late preclinical development

NewGen's strategy is to identify and in-license promising programs, add value through further development and then partner with pharmaceutical companies for clinical development and commercialization. For more information, please visit our website at: http://www.newgenther.com.


'/>"/>
SOURCE NewGen Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... NEW YORK , July 29, 2014 /PRNewswire/ ... team of Caremark Rx, Drew Crawford today ... PBM365 is the leading independent media source dedicated to ... and opinion on the pharmacy benefit management (PBM) industry ... timely coverage of, and context behind, industry news.   The ...
(Date:7/29/2014)... July 29, 2014  Roche (SIX: RO, ROG; OTCQX: ... Clinical Chemistry (AACC) 2014 Clinical Lab Expo today by ... unique ways Roche is partnering with customers to redefine ... tell us every day that they,re looking for a ... in their labs and offices," said Jack Phillips ...
(Date:7/29/2014)... Laboratory (IL) today announced the launch of its new corporate ... of a comprehensive rebranding effort by Werfen, the parent company ... , in 1959, IL has been part of the ... the group include Inova Diagnostics ( San Diego, CA ... ).  Like IL, these three companies are focused on ...
Breaking Medicine Technology:Drew Crawford Announces Launch of PBM365 Media 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... 2007 -,Icagen, Inc. (NASDAQ: ICGN) today announced that ... at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference ... 2:00 p.m. ET., There will be a live ... will be accessible through a link posted on,the ...
... --,SuperGen, Inc. today announced that Dr. Gregory Berk, ... Towbin Emerging Growth,Opportunities Conference on Thursday, July 12, ... City. , SuperGen's presentation at the C.E. Unterberg, ... at 3:30 p.m.,EDT. A live webcast of the ...
Cached Medicine Technology:Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2
(Date:7/29/2014)... discovered a group of new materials capable of ... award worth a combined 2m to find out ... lead to a significant reduction in hospital infections ... health care of hospital patients across the globe. ... the School of Pharmacy and Paul Williams, Professor ...
(Date:7/29/2014)... 2014 CHI-California Healthcare Institute today unveiled ... hepatitis C (hep C) epidemic in the U.S., the ... to reduce human suffering. The report examines key data ... hep C, while highlighting the significance of breakthroughs that ... CHI is a nonprofit, public policy research organization, representing ...
(Date:7/29/2014)... Salt Lake City, UT (PRWEB) July 29, 2014 ... about how Activz produce powders can help parents add ... Magazine article “Little Bites – Key market drivers ... Activz Whole-Food Nutrition, is pleased to announce the ... nutritional benefits of adding the Activz organic vegetable and ...
(Date:7/29/2014)... Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered a ... p53, this protein has been called "the guardian of the ... sense damage to their DNA caused by stress, such as ... UV rays. If the damage is severe, p53 can ... Mutant versions of p53 that no longer perform this vital ...
(Date:7/29/2014)... July 29, 2014 – Silverado, a provider of memory care, ... it is a Bronze winner in the 35th Annual Telly ... a Child's Eye and Silverado Resident Visits Space ... Child's Eye , seven-year-old Mia Sandoval shares her experience coming ... memory care community in Los Angeles. The feel-good video highlights ...
Breaking Medicine News(10 mins):Health News:Bacteria resistant materials -- £2m to get the 'inside' story 2Health News:Bacteria resistant materials -- £2m to get the 'inside' story 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 2Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 3Health News:CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US 4Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:Research may explain how foremost anticancer 'guardian' protein learned to switch sides 2Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2
... people suffering from diabetes is already over 194 million ... 333 million by 2025. Type II diabetes is also ... by a relative disparity between endogenous insulin production and ... to Type I diabetes, there is always some endogenous ...
... cases has reached about 1.2 million worldwide and Statistics show ... urban India and has overtaken cancer of the cervix as ... according to a study conducted on women and cancer in ... motherhood are some factors that can lead to a high ...
... antibiotics may be used to treat childhood cholera. ... children can be treated effectively with a single dose ... study published online by The Lancet., ,Cholera is ... areas in less-developed countries. In the resource-limited countries where ...
... Professor Alice Sigurdson and Colleagues has reported the dosage ... which increases the risk of thyroid cancer. ... were treated for thyroid cancer during their childhood. The ... risk of developing thyroid cancer and there seems to ...
... less at risk from developing the dreaded disease of ... recent issue of Archives of Neurology. ,In previous ... course of a MS-like disease in animals, suggesting that ... postpartum period afterward, both states associated with profound hormonal ...
... children who survive cancer have about twice the rate ... a history of cancer. The study finds children ... children treated with cranial radiation therapy (CRT) are at ... ,As therapies for childhood cancers have become more ...
Cached Medicine News:Health News:Sitagliptin, Under Investigation For Type 2 Diabetes 2Health News:Risk of Thyroid cancer is increased after Childhood Irradiation of Neck region 2Health News:Socialization A Serious Trouble For Childhood Cancer Survivors 2
Multi-constituent normal and abnormal plasma controls for routine and specialty assays performed on the STA© family of hemostasis analyzers....
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
Fructosamine Calibrator...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: